Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate 02:50:03 29/09/2026 pm IST			5-day change	1st Jan Change
60.42 ^EUR	+0.79%		+2.28%	-4.80%

23/07	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
23/07	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Consensus
LABORATORIOS FARMACEUTICOS ROVI, S.A.	348.61Cr		BBB
ELI LILLY AND COMPANY	1,05600Cr		A
JOHNSON & JOHNSON	66TCr	-	BBB	-		-
ABBVIE INC.	47TCr		AAA			-
ROCHE HOLDING AG	34TCr		AA
NOVARTIS AG	28TCr		AAA
ASTRAZENECA PLC	26TCr		A
AMGEN INC.	23TCr		A
GILEAD SCIENCES, INC.	19TCr		AA
NOVO NORDISK A/S	17TCr		BBB
PFIZER INC.	16TCr		A
VERTEX PHARMACEUTICALS INCORPORATED	13TCr		AA
BRISTOL-MYERS SQUIBB COMPANY	13TCr		A
GSK PLC	9.88TCr		AA
SANOFI	9.81TCr		A
CHUGAI PHARMACEUTICAL CO., LTD.	6.65TCr		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	6.02TCr		AA
BAYER AG	5.67TCr		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	4.53TCr		A		-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	4.36TCr		AA
Average	22.72TCr		AA
Weighted average by Cap.			AA